FERMENTALG (ALGAE.PA)

EUR 0.44

(0.0%)

Long Term Debt Summary of FERMENTALG

  • FERMENTALG's latest annual long term debt in 2023 was 14.33 Million EUR , up 40.75% from previous year.
  • FERMENTALG's latest quarterly long term debt in 2024 Q2 was 8.67 Million EUR , down 0.0% from previous quarter.
  • FERMENTALG reported annual long term debt of 10.18 Million EUR in 2022, up 13.16% from previous year.
  • FERMENTALG reported annual long term debt of 9 Million EUR in 2021, down -16.23% from previous year.
  • FERMENTALG reported quarterly long term debt of 8.67 Million EUR for 2024 Q1, down -39.51% from previous quarter.
  • FERMENTALG reported quarterly long term debt of 14.33 Million EUR for 2023 FY, up 40.75% from previous quarter.

Annual Long Term Debt Chart of FERMENTALG (2023 - 2019)

Created with Highcharts 11.1.0YearsLong Term Debt20192019.520202020.520212021.520222022.520230 EUR5000000 EUR10000000 EUR15000000 EUR

Historical Annual Long Term Debt of FERMENTALG (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 14.33 Million EUR 40.75%
2022 10.18 Million EUR 13.16%
2021 9 Million EUR -16.23%
2020 10.74 Million EUR 0.0%
2019 - EUR 0.0%

Peer Long Term Debt Comparison of FERMENTALG

Name Long Term Debt Long Term Debt Difference
Nicox S.A. 25.15 Million EUR 42.997%
European Medical Solutions 12.71 Million EUR -12.756%
argenx SE 15.35 Million EUR 6.617%
BioSenic S.A. 15.57 Million EUR 7.93%
Celyad Oncology SA 902 Thousand EUR -1489.579%
Hyloris Pharmaceuticals SA 344 Thousand EUR -4068.023%
Onward Medical N.V. 16.3 Million EUR 12.069%
Oxurion NV 117 Thousand EUR -12154.701%
PHAXIAM Therapeutics S.A. 7.03 Million EUR -103.954%
Financière de Tubize SA - EUR -Infinity%
UCB SA 2.87 Billion EUR 99.502%